Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Aug;36(1):102-12.
doi: 10.1007/s12035-007-0017-y. Epub 2007 Jul 3.

The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence

Giancarlo Colombo  1 , Alessandro Orrù, Paola Lai, Claudia Cabras, Paola Maccioni, Marina Rubio, Gian Luigi Gessa, Mauro A M Carai
Affiliations
Review

The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence

Giancarlo Colombo et al. Mol Neurobiol. 2007 Aug.

Abstract

Several lines of preclinical evidence indicate the ability of the prototypic cannabinoid CB(1) receptor antagonist, rimonabant, to suppress various alcohol-related behaviors, including alcohol drinking and seeking behavior and alcohol self-administration in rats and mice. Together, these data-synthetically reviewed in the present paper-suggest (a) the involvement of the cannabinoid CB(1) receptor in the neural substrate controlling alcohol intake, alcohol reinforcement, and the motivational properties of alcohol and (b) that rimonabant may constitute a new and potentially effective medication for the treatment of alcohol dependence.

PubMed Disclaimer

References

    1. Neuropharmacology. 2004 Feb;46(2):243-53 - PubMed
    1. Eur J Pharmacol. 1999 Jun 25;374(3):321-7 - PubMed
    1. CNS Drug Rev. 2006 Summer;12(2):91-9 - PubMed
    1. Nat Neurosci. 2005 May;8(5):585-9 - PubMed
    1. FEBS Lett. 1994 Aug 22;350(2-3):240-4 - PubMed

LinkOut - more resources